Dearden C - Search Results

1

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial.

Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Robak T, le Coutre PD, Gjertsen BT, Troussard X, Roboz GJ, Karlin L, Gladstone DE, Kuptsova-Clarkson N, Liu S, Patel P, Rotolo F, Mitry E, Pastan I, Giles F; Study 1053 investigators. Kreitman RJ, et al. Among authors: dearden c. J Hematol Oncol. 2021 Feb 24;14(1):35. doi: 10.1186/s13045-020-01004-y. J Hematol Oncol. 2021. PMID: 33627164 Free PMC article. Clinical Trial.

2

Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.

Dearden CE, Matutes E, Hilditch BL, Swansbury GJ, Catovsky D. Dearden CE, et al. Br J Haematol. 1999 Aug;106(2):515-9. doi: 10.1046/j.1365-2141.1999.01546.x. Br J Haematol. 1999. PMID: 10460614 Free article.

3

Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.

Else M, Ruchlemer R, Osuji N, Del Giudice I, Matutes E, Woodman A, Wotherspoon A, Swansbury J, Dearden C, Catovsky D. Else M, et al. Among authors: dearden c. Cancer. 2005 Dec 1;104(11):2442-8. doi: 10.1002/cncr.21447. Cancer. 2005. PMID: 16245328 Free article.

4

Hairy cell leukemia.

Dearden C, Else M. Dearden C, et al. Curr Oncol Rep. 2006 Sep;8(5):337-42. doi: 10.1007/s11912-006-0055-z. Curr Oncol Rep. 2006. PMID: 16953542 Review.

5

The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.

Else M, Osuji N, Forconi F, Dearden C, Del Giudice I, Matutes E, Wotherspoon A, Lauria F, Catovsky D. Else M, et al. Among authors: dearden c. Cancer. 2007 Nov 15;110(10):2240-7. doi: 10.1002/cncr.23032. Cancer. 2007. PMID: 17886250 Free article.

6

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.

Else M, Dearden CE, Matutes E, Garcia-Talavera J, Rohatiner AZ, Johnson SA, O'Connor NT, Haynes A, Osuji N, Forconi F, Lauria F, Catovsky D. Else M, et al. Br J Haematol. 2009 Jun;145(6):733-40. doi: 10.1111/j.1365-2141.2009.07668.x. Epub 2009 Mar 29. Br J Haematol. 2009. PMID: 19344416 Free article.

7

Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.

Else M, Dearden CE, Matutes E, Forconi F, Lauria F, Ahmad H, Kelly S, Liyanage A, Ratnayake V, Shankari J, Whalley I, Catovsky D. Else M, et al. Leuk Lymphoma. 2011 Jun;52 Suppl 2:75-8. doi: 10.3109/10428194.2011.568650. Epub 2011 Apr 19. Leuk Lymphoma. 2011. PMID: 21504288

8

Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.

Dearden CE, Else M, Catovsky D. Dearden CE, et al. Leuk Lymphoma. 2011 Jun;52 Suppl 2:21-4. doi: 10.3109/10428194.2011.565093. Leuk Lymphoma. 2011. PMID: 21599603 Review.

9

Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials.

CLL Trialists’ Collaborative Group. CLL Trialists’ Collaborative Group. Haematologica. 2012 Mar;97(3):428-36. doi: 10.3324/haematol.2011.053512. Epub 2011 Dec 1. Haematologica. 2012. PMID: 22133773 Free PMC article. Review.

10

GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.

Hawkes EA, Barton S, Cunningham D, Peckitt C, Chua S, Wotherspoon A, Horwich A, Potter M, Ethel M, Dearden C, Chau I. Hawkes EA, et al. Among authors: dearden c. Ann Hematol. 2014 May;93(5):827-34. doi: 10.1007/s00277-013-1930-y. Epub 2013 Oct 26. Ann Hematol. 2014. PMID: 24158386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters